Kandi Technologies (KNDI) Pops Again

Joel Anderson |

Shares in Chinese electric vehicle maker Kandi Technologies (KNDI) spiked over 10 percent on Monday. The small-cap manufacturer has a wild day as it gapped down over 3 percent to open trading, then saw shares spike an hour into the day. Gains reach as high as 12 percent before profit-taking prompted gains to retract to around 9 percent by mid-afternoon.

Kandi Sweet to Investors of Late

Kandi Technologies has been on a run since the start of September, up almost 70 percent over that period. It cooled of late, retreating from its 52-week high of $9.20 a share it reached on September 25, but today’s gains bring the stock back to close to $8 a share.

China’s Electric Vehicle Subsidies Driving Growth

The recent spike for Kandi appears to be connected to the announcement of subsidies from the Chinese government for purchasing electric vehicles. The subsidies, which range from 60,000 Yuan (almost $10,000) to 35,000 Yuan (just under $5,750) depending on the range of the vehicle purchased, should make Kandi’s offerings more available to consumers in China. Kandi’s low-speed electric vehicles, in particular, should become more attractive.

Driving to a Better Future?

Kandi’s outlook appears, with deals to provide some 20,000 electric vehicles to the city of Hangzhou’s electric vehicle leasing program, and a joint research and development venture with Shanghai Maple (GELYY) . China’s market for alternative-energy vehicles appears to be on the rise, and the new subsidies would seem to indicate that the central government is committed to seeing a transition to more electric vehicles. And, with the subsidies based on range rather than battery capacity, Kandi should maintain a price advantage over offerings from luxury brand Tesla Motors (TSLA) .

However, Kandi could face headwinds from increasing competition in the segment. The coming years should see a number of auto-makers jump into the Chinese market for electric vehicles, including Daimler AG (DDAIY) and Toyota (TM) .

As a side note, Equities.com has included Kandi in our ongoing Small-Cap Stars Project.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Spotlight

BiondVax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd Ltd is a clinical stage biopharmaceutical company. The Company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.

Events

EQUITIES Emerging Growth and Innovation Forum

EQUITIES Inaugural Emerging Growth and Innovation Forum at Disruptive firm MRY New York City's Flatiron District. The forum is on February 24th from 12:00 pm to 6:00 pm with a…

Learn more

Research

MagneGas Corporation (MNGA)

MagneGas Corporation is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification and sterilization of liquid and liquid waste. ($49 USD)

Learn more

Private Markets

SU Labs Accelerator Seed Fund

We're a fiercely passionate community of entrepreneurs leveraging rapidly accelerating technologies to create a brighter future. Join us in fostering innovation, driving impact and funding the future.

FAB Financial Inc.

Banking is broken. Years ago people who needed business advice would turn to their local bank manager for help. The banker was thought of as a trusted member of the…